Maple Grove, Minnesota-based Entellus Medical, which has developed minimally invasive treatments for chronic sinusitis, announced Wednesday that it has raised $35 million in its fifth round of financing. The round was led by new investor Covidien Ventures, a venture capital firm that invests in companies developing new innovative medical devices, diagnostics and pharmaceuticals. Aside from […]
Entellus Medical Inc., which is developing a less-invasive therapy to treat chronic sinusitis, has hired a new chief executive. Brian Farley, who has served on the company’s board since 2008 and previously led VNUS Medical Technologies Inc., takes over the CEO job from Entellus co-founder Tom Ressemann, according to a company statement. Ressemann will stay […]
Quantity or quality? Like most things in life, that’s not always an either/or question. Most people would prefer both. But as the University of Minnesota starts to shop its intellectual property a little more aggressively to investors, as evidenced by its first Life Sciences Showcase event at University Enterprise Laboratories Thursday morning, it’s something to […]
Midwest health care start-ups attracted $780 million in investments in 2009, according to the BioEnterprise Midwest Health Care Venture Investment Report. While the number of companies winning investments last year -- 156 -- was about the same as in 2008, the dollar volume of the investments dropped 26 percent.
The development is an important milestone for the company as it endeavors to convince more insurers to cover its FinESS sinus treatment in an office setting.
The company will use the funding to expand its sales and customer support teams, and prepare to launch its sinus-treatment system in Europe.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
